COVID-19 and the cardiovascular system

Cited by (1,006)

Items 501–600 of 1,006

1. Could autism spectrum disorders be a risk factor for COVID-19?
   Matheus Eugênio de Sousa Lima, Levi Coelho Maia Barros, Gislei Frota Aragão · 2020 · Medical Hypotheses
2. Usefulness of echocardiography to detect cardiac involvement in COVID‐19 patients
   Matteo Cameli, Maria Concetta Pastore, Hatem Soliman-Aboumarie, Giulia Elena Mandoli, Flavio D’Ascenzi, Paolo Cameli, Elisa Bigio, Federico Franchi, Sergio Mondillo, Serafina Valente · 2020 · Echocardiography
3. Early Research on COVID-19: A Bibliometric Analysis
   Yue Gong, Tingcan Ma, Yang-yang Xu, Rui Yang, Lan-jun Gao, Sihua Wu, Jing Li, Mingliang Yue, Huigang Liang, He Xiao et al. · 2020 · The Innovation
4. The effect of the severity COVID-19 infection on electrocardiography
   Hasan Ali Barman, Adem Atıcı, Gökhan Alıcı, Omer Sit, Sevil Tuğrul, Barış Güngör, Ertuğrul Okuyan, İrfan Şahin · 2020 · The American Journal of Emergency Medicine
5. A gradient boosting machine learning approach in modeling the impact of temperature and humidity on the transmission rate of COVID-19 in India
   Lokesh Kumar Shrivastav, Sunil Kumar Jha · 2020 · Applied Intelligence
6. Acute myocardial infarction secondary to COVID-19 infection: A case report and review of the literature
   Kathleen M. Capaccione, Jay S. Leb, Belinda M. D’Souza, Pallavi S. Utukuri, Mary M. Salvatore · 2020 · Clinical Imaging
7. COVID-19: Molecular and Cellular Response
   Shamila D. Alipoor, Esmaeil Mortaz, Hamidreza Jamaati, Payam Tabarsi, Hasan Bayram, Mohammad Varahram, Ian Michael Adcock · 2021 · Frontiers in Cellular and Infection Microbiology
8. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review
   Vijay Viswanathan, Anudeep Puvvula, Ankush D. Jamthikar, Luca Saba, Amer M. Johri, Vasilios Kotsis, Narendra Nath Khanna, Surinder K. Dhanjil, Misha Majhail, Durga Prasanna Misra et al. · 2021 · World Journal of Diabetes
9. A System for Remote Monitoring of Patient Body Parameters
   Pushpa Choudhary, Suman Avdhesh Yadav, Arun Pratap Srivastava, Arjun Singh, Smita Sharma · 2021 · International Conference on Technological Advancements and Innovations (ICTAI)
10. Épidémie de COVID-19 et prise en charge des conduites suicidaires : challenge et perspectives
    Ismaël Conejero, Sofian Berrouiguet, Déborah Ducasse, Marion Leboyer, Vincent Jardon, Émilie Olié, Philippe Courtet · 2020 · L Encéphale
11. Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality
    Zena Wehbe, Safaa H. Hammoud, Hadi Mohamad Yassine, Manal Fardoun, Ahmed Fawzy EL‐Yazbi, Ali Hussein Eid · 2021 · Frontiers in Immunology
12. Antiviral and Anti‐Inflammatory Treatment with Multifunctional Alveolar Macrophage‐Like Nanoparticles in a Surrogate Mouse Model of COVID‐19
    Bin Li, Wei Wang, Weifeng Song, Zheng Zhao, Qingqin Tan, Zhaoyan Zhao, Lantian Tang, Tianchuan Zhu, Jialing Yin, Jun Yuan Bai et al. · 2021 · Advanced Science
13. Cardiovascular Disease As A Biomarker for An Increased Risk of Covid-19 Infection and Related Poor Prognosis
    Nicola Ielapi, Noemi Licastro, Michele Provenzano, Michele Andreucci, Stefano de Franciscis, Raffaele Serra · 2020 · Biomarkers in Medicine
14. Salivary diagnostics in COVID-19: Future research implications
    VC Divya, Saravana Karthikeyan Balasubramanian · 2020 · Journal of Dental Sciences
15. A Simple Clustering Strategy for Wireless Sensor Networks
    Waltenegus Dargie, Jianjun Wen · 2020 · IEEE Sensors Letters
16. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)
    Calvin Chen Sheng, Debasis H Sahoo, Siddharth Pawan Dugar, Robier Aguillon Prada, Tom Kai Ming Wang, Ossama K. Abou Hassan, Danielle M. Brennan, Daniel A. Culver, Prabalini Rajendram, Abhijit Duggal et al. · 2020 · Clinical Cardiology
17. Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study
    Didier Collard, Nick S. Nurmohamed, Yannick Kaiser, Laurens F. Reeskamp, Tom P.J. Dormans, Hazra S. Moeniralam, Suat Şimşek, Renée A. Douma, Annet Eerens, Auke C. Reidinga et al. · 2021 · BMJ Open
18. Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function
    R. Clayton Edenfield, Charles A. Easley · 2021 · Nature Reviews Urology
19. Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks
    Alexander M. Tatara · 2020 · Tissue Engineering Part A
20. A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19)
    Maryam Rameshrad, Majid Ghafoori, Amir Hooshang Mohammadpour, Mohammad Javad Dehghan Nayeri, Hossein Hosseinzadeh · 2020 · Naunyn-Schmiedeberg s Archives of Pharmacology
21. Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production
    Xin-Tong Wang, Zhen Peng, Ying-Ying An, Ting Shang, Guangxu Xiao, Shuang He, Xi Chen, Han Zhang, Yuefei Wang, Tao Wang et al. · 2021 · Frontiers in Pharmacology
22. Effect of Biomedical Materials in the Implementation of a Long and Healthy Life Policy
    L. A. Dobrzański, Anna Danuta Dobrzańska-Danikiewicz, Lech B. Dobrzański · 2021 · Processes
23. Neutrophil Extracellular Traps in Fatal COVID-19-Associated Lung Injury
    Astrid Obermayer, Lisa-Maria Jakob, Jasmin D. Haslbauer, Matthias Sebastian Matter, Alexandar Tzankov, Walter Stoiber · 2021 · Disease Markers
24. Burden and prevalence of prognostic factors for severe COVID-19 in Sweden
    Katalin Gémes, Mats Talbäck, Karin Modig, Anders Ahlbom, Anita Berglund, Maria Feychting, Anthony Matthews · 2020 · European Journal of Epidemiology
25. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients
    Álvaro Lorente-Ros, Juan Manuel Monteagudo Ruiz, Leonardo Mejia Rincon, Rodrigo Ortega Pérez, Sonia Rivas Fidalgo, Rafael Rodrigo Martínez Moya, M Sanroman, Luís Manzano, Gonzalo Luis Alonso Salinas, Borja Ibáñez et al. · 2020 · Cardiology Journal
26. Sex Differences in Mortality Rates and Underlying Conditions for COVID-19 Deaths in England and Wales
    Mohamed Mohamed, Chris P Gale, Evangelos Kontopantelis, Tim Doran, Mark de Belder, Miqdad Asaria, Thomas Felix Lüscher, Jianhua Wu, Muhammad Owais Rashid, Courtney Stephenson et al. · 2020 · Mayo Clinic Proceedings
27. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities
    Md Asif Nashiry, Shauli Sarmin Sumi, Salequl Islam, Julian M.W. Quinn, Mohammad Ali Moni · 2020 · Briefings in Bioinformatics
28. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID‐19: Insight From a French Multicenter Cohort Study
    Richard Chocron, Vincent Galand, Joffrey Cellier, Nicolas Gendron, Thibaut Pommier, Olivier Bory, Lina Khider, Antonin Trimaille, Guillaume Goudot, Orianne Weizman et al. · 2021 · Journal of the American Heart Association
29. A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis
    Adedayo A. Adeboye, Deya A. Alkhatib, Asra Khalid Butt, Neeraja Yedlapati, Nadish Garg · 2022 · Diagnostics
30. Cellulose Nanocrystal-Based All-3D-Printed Pyro-Piezoelectric Nanogenerator for Hybrid Energy Harvesting and Self-Powered Cardiorespiratory Monitoring toward the Human–Machine Interface
    Kuntal Maity, Anirban Mondal, Mrinal C. Saha · 2023 · ACS Applied Materials & Interfaces
31. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study
    Richard Chocron, Baptiste Duceau, Nicolas Gendron, Nacim Ezzouhairi, Lina Khider, Antonin Trimaille, Guillaume Goudot, Orianne Weizman, Jean-Marc Alsac, Thibault Pommier et al. · 2021 · Archives of cardiovascular diseases
32. Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach
    Yanni Lv, Saisai Wang, Peida Liang, Yamin Wang, Xin Zhang, Qianqian Jia, Jia Fu, Shengli Han, Langchong He · 2021 · Analytical and Bioanalytical Chemistry
33. Inside the heart of COVID-19
    Rui Adão, Tomasz Jan Guzik · 2020 · Cardiovascular Research
34. Well-controlled vs poorly-controlled diabetes in patients with COVID-19: Are there any differences in outcomes and imaging findings?
    Masoomeh Raoufi, Shayesteh Khalili, Mohsen Mansouri, Ali Mahdavi, Neda Khalili · 2020 · Diabetes Research and Clinical Practice
35. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease
    Jiatian Cao, Yan Zheng, Zhe Luo, Zhendong Mei, Yumeng Yao, Zilong Liu, Chao Liang, Hongbo Yang, Yanan Song, Kaihuan Yu et al. · 2020 · Theranostics
36. Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19
    Antonio Vitiello, Francesco Ferrara · 2020 · Life Sciences
37. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19
    Eileen M. McGowan, Nahal Haddadi, Najah Therese Nassif, Yiguang Lin · 2020 · International Journal of Molecular Sciences
38. Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium
    Sonu M. M. Bhaskar, Aarushi Rastogi, Vijay Kumar Chattu, Anil Adisesh, Pravin Thomas, Negman Alvarado, Anis D. Riahi, Chakrakodi N. Varun, Anupama Ramakanth Pai, Sarah J. Barsam et al. · 2020 · Frontiers in Cardiovascular Medicine
39. Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective
    Azita H. Talasaz, Hessam Kakavand, Benjamin W. Van Tassell, Maryam Aghakouchakzadeh, Parham Sadeghipour, Steven P. Dunn, Babak Geraiely · 2020 · Cardiovascular Drugs and Therapy
40. Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
    Kholoud F. Aliter, Rami A. Al‐Horani · 2020 · Cardiovascular Drugs and Therapy
41. Delicate Role of PD-L1/PD-1 Axis in Blood Vessel Inflammatory Diseases: Current Insight and Future Significance
    Priya Veluswamy, Max Wacker, Maximilian Philipp Scherner, Jens Wippermann · 2020 · International Journal of Molecular Sciences
42. Notable Developments for Vitamin D Amid the COVID-19 Pandemic, but Caution Warranted Overall: A Narrative Review
    Ronan Lordan · 2021 · Nutrients
43. 3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomography
    Marius Reichardt, Patrick M. Jensen, Vedrana Andersen Dahl, Anders Bjorholm Dahl, Maximilian Ackermann, Harshit Shah, Florian Peter Länger, Christopher Werlein, Mark Kühnel, Danny David Jonigk et al. · 2021 · eLife
44. Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)
    Cameron Grant McCarthy, Piu Saha, Rachel M. Golonka, Camilla Ferreira Wenceslau, Bina Joe, Matam Vijay–Kumar · 2021 · Comprehensive physiology
45. Screening and testing for COVID ‐19 before surgery
    Joshua George Kovoor, David R. Tivey, Penny Williamson, Lorwai Tan, Helena S. Kopunic, Wendy Babidge, Trevor G. Collinson, Peter J. Hewett, Thomas J. Hugh, Robert T. A. Padbury et al. · 2020 · ANZ Journal of Surgery
46. COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
    Mário Roberto Senger, Tereza Cristina Santos Evangelista, Rafael Ferreira Dantas, Marcos V. Santana, Luiz Carlos Saramago Gonçalves, Lauro Ribeiro de Souza Neto, Sabrina Baptista Ferreira, Floriano Paes Silva · 2020 · Memórias do Instituto Oswaldo Cruz
47. Mechanisms of COVID-19 pathogenesis in diabetes
    Chandrakala Aluganti Narasimhulu, Dinender Kumar Singla · 2022 · American Journal of Physiology-Heart and Circulatory Physiology
48. ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition—implications for COVID-19
    Julia S. El-Sayed Moustafa, Anne Jackson, Sarah M. Brotman, Li Guan, Sergio Villicaña, Amy L. Roberts, Antonino Zito, Lori L. Bonnycastle, Michael R. Erdos, Narisu Narisu et al. · 2022 · International Journal of Obesity
49. Coronavirus 2019 Disease (COVID‐19), Systemic Inflammation, and Cardiovascular Disease
    Riccardo Maria Inciardi, Scott David Solomon, Paul M. Ridker, Marco Metra · 2020 · Journal of the American Heart Association
50. A Comparison of Clinical Characteristics and Outcomes in Elderly and Younger Patients with COVID-19
    Jia Song, Weihang Hu, Yihua Yu, Xin Shen, Yueben Wang, Jin Yan, Xianghong Yang, Shijin Gong, Minjia Wang · 2020 · Medical Science Monitor
51. Review: penyakit virus corona baru 2019 (COVID-19)
    Nany Hairunisa, Husnun Amalia · 2020 · Jurnal Biomedika dan Kesehatan
52. Pathophysiology of Cardiovascular Complications in COVID-19
    Vladimír Petrovič, Dina Radenković, Goran Radenković, Vukica Djordjevic, Maciej Banach · 2020 · Frontiers in Physiology
53. Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality
    Mary Flook, Charlotte Jackson, Eleftheria Vasileiou, Colin R Simpson, Marisa D. Muckian, Utkarsh Agrawal, Colin McCowan, Yifan Jia, Josie Murray, Lewis Duthie Ritchie et al. · 2021 · BMC Infectious Diseases
54. Biosensors as Nano-Analytical Tools for COVID-19 Detection
    Anchal Pradhan, Preeti Lahare, Priyank Sinha, Namrata Singh, Bhanushree Gupta, Kamil Kuča, Kallol Kumar Ghosh, Ondřej Krejcar · 2021 · Sensors
55. COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy?
    Aneta Aleksova, Federico Ferro, Giulia Gagno, Chiara Cappelletto, Daniela Santon, Maddalena Rossi, Giuseppe Ippolito, Alimuddin I. Zumla, Antonio Paolo Beltrami, Gianfranco Sinagra · 2020 · Journal of Internal Medicine
56. Behavior of the PR interval with increasing heart rate in patients with COVID-19
    Behzad B. Pavri, Juergen Kloo, Darius Farzad, Joshua M. Riley · 2020 · Heart Rhythm
57. COVID‐19 in recent heart transplant recipients: Clinicopathologic features and early outcomes
    Brian Lima, Gregory T. Gibson, Sirish Vullaganti, Kathryn Malhame, Simon W. Maybaum, Syed Tarique Hussain, Samit Shah, David T. Majure, Fran Wallach, Kristine H Jang et al. · 2020 · Transplant Infectious Disease
58. Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities
    Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Stavropoulos, Konstantinos P. Imprialos, Maria‐Styliani Kalogirou, Michael N. Doumas · 2020 · Current Hypertension Reports
59. Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
    Girish Pathangey, Priyal Fadadu, Alexa R. Hospodar, Amr E. Abbas · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
60. Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research
    Sergio Daga, Chiara Fallerini, Margherita Baldassarri, Francesca Fava, Floriana Valentino, Gabriella Doddato, Elisa Benetti, Simone Furini, Annarita Giliberti, Rossella Tita et al. · 2021 · European Journal of Human Genetics
61. Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19
    Christopher M. Rice, Philip A. Lewis, Fernando M. Ponce-Garcia, Willem Gibbs, Sarah Groves, Drinalda Cela, Fergus Hamilton, David Arnold, Catherine J. Hyams, Elizabeth Oliver et al. · 2022 · Life Science Alliance
62. Two-Years Follow-Up of Symptoms and Return to Work in Complex Post-COVID-19 Patients
    Erika Van Wambeke, Cécile Bezler, Anne-Marie Kasprowicz, Anne‐Laure Charles, Emmanuel Andrès, Bernard Gény · 2023 · Journal of Clinical Medicine
63. Biomimetic Nanomaterial Strategies for Virus Targeting: Antiviral Therapies and Vaccines
    Joshua A. Jackman, Bo Kyeong Yoon, Lei Ouyang, Nan Wang, Abdul Rahim Ferhan, Jaeyun Kim, Tetsuro Majima, Nam‐Joon Cho · 2020 · Advanced Functional Materials
64. Smart textiles and wearable technologies – opportunities offered in the fight against pandemics in relation to current COVID-19 state
    Aleksandra Ivanoska-Dacikj, Urszula Stachewicz · 2020 · REVIEWS ON ADVANCED MATERIALS SCIENCE
65. Venous thromboembolic events in patients with COVID-19: a systematic review and meta-analysis
    Ting Wu, Zhihong Zuo, Deyi Yang, Xuan Luo, Liping Jiang, Zanxian Xia, Xiaojuan Xiao, Jing Liu, Mao Ye, Meichun Deng · 2020 · Age and Ageing
66. Three-Dimensional Virtual Anatomy as a New Approach for Medical Student’s Learning
    Anna Bartoletti‐Stella, Valentina Gatta, Giulia Adalgisa Mariani, Pietro Gobbi, Mirella Falconi, Lucia Manzoli, Irene Faenza, Sara Salucci · 2021 · International Journal of Environmental Research and Public Health
67. Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications
    Zaid A. Abassi, Suheir Assady, Emad E. Khoury, Samuel Noam Heyman · 2020 · American Journal of Physiology-Heart and Circulatory Physiology
68. Патогенез COVID-19
    А.Е. Абатуров, Е.А. Агафонова, Е Л Кривуша, А.О. Нікуліна · 2020 · CHILD`S HEALTH
69. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID ‐19 in ST ‐segment elevation myocardial infarction patients
    Thibaud Lacour, Carl Semaan, Thibaud Genet, Fabrice Ivanés · 2020 · Catheterization and Cardiovascular Interventions
70. Can vitamin B12 be an adjuvant to COVID-19 treatment?
    Lopes Monyck Jeane dos Santos · 2020 · GSC Biological and Pharmaceutical Sciences
71. Anti‐heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID‐19
    Olga V. Blagova, N. V. Varionchik, В. А. Зайденов, P. O. Savina, Natalia D. Sarkisova · 2020 · European Journal of Immunology
72. Vaccines for COVID-19: A Systematic Review of Feasibility and Effectiveness
    Esmaeil Mehraeen, Omid Dadras, Amir Masoud Afsahi, Amirali Karimi, Mehrzad MohsseniPour, Pegah Mirzapour, Alireza Barzegary, Farzane Behnezhad, Pedram Habibi, Mohammad Amin Salehi et al. · 2021 · Infectious Disorders - Drug Targets
73. COVID-19: systemic pathology and its implications for therapy
    Qi Shen, Jie Li, Zhan Zhang, Shuang Guo, Qiuhong Wang, Xiaorui An, Haocai Chang · 2021 · International Journal of Biological Sciences
74. COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings
    Recep Öztürk, Yeşim Taşova, Akif Ayaz · 2020 · TURKISH JOURNAL OF MEDICAL SCIENCES
75. COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes
    Arumugam Vijaya Anand, Thangavelu Sangeetha, Zareena Fathah, Ravindran Pavithra, Ann Mary Alappat Sanjeev, Sunantha Babu, Arun Meyyazhagan, Mohd. Iqbal Yatoo, Khan Sharun, Ruchi Tiwari et al. · 2020 · Journal of Pure and Applied Microbiology
76. Bayesian spatiotemporal forecasting and mapping of COVID‐19 risk with application to West Java Province, Indonesia
    I Gede Nyoman Mindra Jaya, Henk Folmer · 2021 · Journal of Regional Science
77. Endocrine Conditions and COVID-19
    Skand Shekhar, Rachel Wurth, Crystal Dawn Chrysavgi Kamilaris, Graeme Eisenhofer, Francisco J. Barrera, Michelle Hajdenberg, Joselyne Tessa Tonleu, Janet Elizabeth Hall, Ernesto L. Schiffrin, Forbes D. Porter et al. · 2020 · Hormone and Metabolic Research
78. Heart block in patients with coronavirus disease 2019: A case series of 3 patients infected with SARS-CoV-2
    TALA ENEIZAT MAHDAWI, Haoyang Wang, Faris I. Haddadin, Dalya Al-Qaysi, John V. Wylie · 2020 · HeartRhythm Case Reports
79. COVID-19 in patients with heart failure: the new and the old epidemic
    Nicolò Sisti, Serafina Valente, Giulia Elena Mandoli, Ciro Santoro, Carlotta Sciaccaluga, Federico Franchi, Paolo Cameli, Sergio Mondillo, Matteo Cameli · 2020 · Postgraduate Medical Journal
80. SARS-CoV-2 infection and thrombotic complications: a narrative review
    Iraklis C. Moschonas, Alexandros D. Tselepis · 2021 · Journal of Thrombosis and Thrombolysis
81. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment
    Jinwen Luo, Xiao Zhu, Jie Jian, Xu Chen, Kai Yin · 2020 · Acta Biochimica et Biophysica Sinica
82. The cGAS-STING pathway in cardiovascular diseases: from basic research to clinical perspectives
    Cheng An, Zhen Li, Yao Chen, Shaojun Huang, Fan Yang, Ying Hu, Tao Xu, Chengxin Zhang, Shenglin Ge · 2024 · Cell & Bioscience
83. Acute Fulminant Myocarditis in a Pediatric Patient With COVID-19 Infection
    Diego Armando Alvarado Lara, Thomas K. Young, Kamill Del Toro, C. Chan, Cora Ianiro, Kenneth E. Hunt, Jake A. Kleinmahon · 2020 · PEDIATRICS
84. Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing
    Jayanta Kumar Das, Giuseppe Tradigo, Pierangelo Veltri, Pietro Hiram Guzzi, Swarup Roy · 2020 · Briefings in Bioinformatics
85. COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart
    Maurizio Pesce, Piergiuseppe Agostoni, Hans Erik Bøtker, Bianca J.J.M. Brundel, Sean M. Davidson, Raffaele De Caterina, Péter Ferdinandy, Henrique Girão, Mariann Gyöngyösi, Jean‐Sébastien Hulot et al. · 2021 · Cardiovascular Research
86. Antihypertensive drugs and risk of COVID-19? – Authors' reply
    Lei Fang, George Karakiulakis, Michael Roth · 2020 · The Lancet Respiratory Medicine
87. Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
    Annamaria Mascolo, Cristina Scavone, Concetta Rafaniello, Carmen Ferrajolo, Giorgio Racagni, Liberato Berrino, Giuseppe Paolisso, Francesco Rossi, Annalisa Capuano · 2020 · Frontiers in Cardiovascular Medicine
88. Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities
    Lu Wang, Yinan Sun, Ye Yuan, Qi Mei, Xianglin Yuan · 2020 · Aging
89. COVID-19 e Injúria Miocárdica em UTI Brasileira: Alta Incidência e Maior Risco de Mortalidade Intra-Hospitalar
    Jorge Henrique Paiter Nascimento, Rafael Lessa da Costa, Luiz Fernando Nogueira Simvoulidis, João Carlos de Pinho, Roberta Santos Pereira, Andrea Dornelles Porto, Eduardo Costa de Freitas Silva, Liszt Palmeira de Oliveira, Max Rogério Freitas Ramos, Gláucia Maria Moraes de Oliveira · 2021 · Arquivos Brasileiros de Cardiologia
90. Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study
    Rahul Parit, Sridhar Jayavel · 2021 · European Journal of Pharmacology
91. Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: A systematic review
    Andrea Boscutti, Giuseppe Delvecchio, Alessandro Pigoni, Guido Cereda, Valentina Ciappolino, Marcella Bellani, Paolo Fusar‐Poli, Paolo Brambilla · 2021 · Brain Behavior & Immunity - Health
92. An Artificial Intelligence Based Technique for COVID-19 Diagnosis from Chest X-Ray
    Saddam Bekhet, M. Hassaballah, Mourad A. Kenk, Mohamed Abdel Hameed · 2020 · Novel Intelligent and Leading Emerging Sciences Conference (NILES)
93. Temperature–Pressure Hybrid Sensing All-Organic Stretchable Energy Harvester
    Sujoy Kumar Ghosh, Tridib Kumar Sinha, Mengying Xie, Chris Bowen, Samiran Garain, Biswajit Mahanty, Krittish Roy, Karsten Henkel, Dieter Schmeißer, Jin Kuk Kim et al. · 2020 · ACS Applied Electronic Materials
94. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications
    Alessandra Stasi, Rossana Franzin, Marco Fiorentino, Enrico Squiccimarro, Giuseppe Castellano, Loreto Gesualdo · 2021 · International Journal of Molecular Sciences
95. Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis
    Nathalie Verónica Fernández Villalobos, Jördis Jennifer Ott, Carolina Judith Klett-Tammen, Annabelle J. Bockey, Patrizio Vanella, Gérard Krause, Berit Lange · 2021 · Systematic Reviews
96. Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective
    Giacomo Ruzzenenti, Alessandro Maloberti, Valentina Giani, Marco Biolcati, Filippo Leidi, Massimiliano Monticelli, Enzo GRASSO, Iside Cartella, Matteo Palazzini, Laura Garatti et al. · 2021 · High Blood Pressure & Cardiovascular Prevention
97. ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System
    Véronique Michaud, Malavika Deodhar, Meghan J. Arwood, Sweilem B. Al Rihani, Pamela Dow, Jacques Turgeon · 2020 · Journal of Clinical Medicine
98. Heart, COVID‐19, and echocardiography
    Lidia Capotosto, Bich Lien Nguyen, Maria Rosa Ciardi, Claudio Maria Mastroianni, Antonio Vitarelli · 2020 · Echocardiography
99. Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance
    Vanessa M. Ferreira, Sven Plein, Timothy C. Wong, Qian Tao, Zahra Raisi‐Estabragh, Supriya Jain, Yuchi Han, Vineeta Ojha, David A. Bluemke, Kate A Hanneman et al. · 2023 · Journal of Cardiovascular Magnetic Resonance
100. SARS-CoV-2 (COVID-19): New Discoveries and Current Challenges
     Ghazaleh Jamalipour Soufi, Ali Hekmatnia, Mahmoud Nasrollahzadeh, Nasrin Shafiei, Mohaddeseh Sajjadi, Parisa Iravani, Salman Fallah, Siavash Iravani, Rajender S. Varma · 2020 · Applied Sciences